| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.3 | 0.06 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.26 | 0.07 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.084 | 0.07 |